SCHEMBL25751813

SCHEMBL25751813

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc(-c5cccc(-c6ccc7c(c6)c6ccccc6n7-c6ccc7oc(-c8ccccc8)nc7c6)c5)nc4c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPSE Q9Y251 7/20 0.44
▸ SMN1; SMN2 Q16637 5/20 0.42
▸ NPC1 O15118 5/20 0.42
▸ RAB9A P51151 5/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ CASP3 P42574 2/20 0.42
▸ SENP7 Q9BQF6 2/20 0.42
▸ SENP6 Q9GZR1 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ UTRN P46939 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ GFER P55789 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ S1PR1 P21453 2/20 0.38
▸ S1PR3 Q99500 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25751921 0.95 HPSE (0.41) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25459469 0.95 HPSE (0.47) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25751763 0.94 HPSE (0.49) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL27049522 0.94 HPSE (0.46) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25459466 0.94 HPSE (0.47) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25459462 0.94 NPC1 (0.43) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25459475 0.92 NPC1 (0.43) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25751805 0.92 HPSE (0.40) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25459612 0.92 SMN1; SMN2 (0.45) HPSESMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25459777 0.92 NPC1 (0.49) SMN1; SMN2NPC1RAB9AKDM4ECASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX HPSE 3938/4885SMN1; SMN2 4240/4885NPC1 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback